Literature DB >> 20854118

New and known β-thalassemia determinants masked by known and new δ gene defects [Hb A(2)-Ramallah or δ6(A3)Glu→Gln, GAG>>CAG].

Marion Phylipsen1, Cornelis L Harteveld, Menno de Metz, Monica V E Gallivan, Sandra G J Arkesteijn, Hong-Yuan Luo, David H K Chui, Piero C Giordano.   

Abstract

We report a novel thalassemia determinant found in a Nigerian woman living in the Netherlands, resulting from a 2 bp insertion at codons 9/10 of the β-globin gene (HBBc.28_29insTA p.Ser10LeufsX11). The novel defect causes a frameshift with a consequent premature TGA stop codon, located at 11 positions downstream from the mutated codon. The phenotype was typical of a β-thalassemia (β-thal), trait with high RBC counts and compensated mild microcytic anemia. However, the Hb A(2) level was reported to be normal due to the presence of the common Hb A(2)' or Hb B2 [δ16(A13)GlyArg, GGC>CGC] variant that was not taken into account. We also present the opposite but comparable situation found in an a Palestinian man living in the USA. He was a carrier of a common β-globin gene defect [codon 6 (-A), HBB:c.20delA] in combination with a novel δ-globin gene defect at codon 6 [HBD. c.19G>C, Glu6Gln] that we have named Hb A(2)-Ramallah. In both cases, the provisional diagnosis could have been compromised when based on the measurement of the normal Hb A(2) fraction only.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854118     DOI: 10.3109/03630269.2010.511591

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Screening for the beta-thalassaemia trait: hazards among populations of West African Ancestry.

Authors:  Felicea Gibson; Karlene Mason; Beryl Serjeant; Andreas Kulozik; Margit Happich; Gabriele Tolle; Ian Hambleton; Graham Serjeant
Journal:  J Community Genet       Date:  2011-11-03

Review 2.  The prevention of thalassemia.

Authors:  Antonio Cao; Yuet Wai Kan
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

3.  Significance of borderline HbA2 levels in β thalassemia carrier screening.

Authors:  Stacy Colaco; Roshan Colah; Anita Nadkarni
Journal:  Sci Rep       Date:  2022-03-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.